UT MD Anderson Cancer Center, Houston, TX.

This drug is aimed at preventing the recurrence of fully resected, lung metastatic osteosarcoma. According to InvestingPro analysis, the company maintains a favorable cash position relative to ...

The status has been given to the B7-H3-targeted drug as a treatment for late-line relapsed or refractory osteosarcoma, a rare form of bone cancer with no FDA-approved treatments. The coveted ...

Written response-only meeting to align analysis plan of surrogate endpoint to support Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully ...

Jalen passed away at age 15 from osteosarcoma, a childhood cancer. His mother founded the nonprofit Jalen Nation to fulfill his dream of helping pediatric cancer patients. "Sometimes kids battling ...

Key data will be presented from the Company’s Phase 2b clinical trial of OST-HER2 in the prevention of recurrent, fully resected, lung metastatic osteosarcoma. NEW YORK, March 11, 2025--OS ...

He was a 19-year-old freshman − a 6-foot-6, 300-pound offensive lineman − when he was first diagnosed with osteosarcoma, an aggressive form of bone cancer.

A new wave of scientific interest is spotlighting GOT2—glutamic-oxaloacetic transaminase 2—as a compelling therapeutic target in the fight against pancreatic cancer, one of the most lethal and ...

This drug is aimed at preventing the recurrence of fully resected, lung metastatic osteosarcoma. According to InvestingPro analysis, the company maintains a favorable cash position relative to debt, ...